CALA - Cardiac Arrhythmia Laser Ablation

Atrial fibrillation is one of the most common rhythm disorders in Europe. It is estimated that about 15 million people will suffer in Europe by 2030 [1].

Atrial fibrillation are arrhythmias that are triggered by additional irregular electrical impulses (extra beats from the atrium).

The therapeutic approach of catheter ablation serves to eliminate the source and pathways that cause the chaotic electrical signals in the heart. In this way, normal sinus rhythm can be restored in the heart.

In this field, biolitec® is currently developing a solution called CALA (Cardiac Arrhythmia Laser Ablation), in which the disturbing conduction paths are specifically ablated by the resulting laser energy and thus electrically inactivated in a controlled manner.

With the new biolitec® FPS system there is no danger of overheating and thus less chances of damage to the surrounding tissue.


Sources:

  1. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014; 6:213–220. doi: 10.2147/CLEP.S47385